Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04968782 · ClinicalTrials.gov registry record
Appendicitis Choice of Treatment Study
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 23
- Enrollment target
NCT04968782: Completed study, sponsored by University of Washington.
NCT04968782 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04968782 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
A longitudinal observational/survey study evaluating patient centered decision making in the choice of treatment for acute appendicitis. Survey evaluates patients experience with decision making and the types of decision support they receive.
Primary Outcome
Validated evaluation of decision making
Interventions
- OTHER Patients with acute appendicitis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2021-07-12 |
| Est. Completion | 2022-02-16 |
What the finished NCT04968782 record still lists
NCT04968782 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Patients with acute appendicitis is the first listed.
NCT04968782 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04968782 about?
NCT04968782 is a clinical study titled "Appendicitis Choice of Treatment Study". A longitudinal observational/survey study evaluating patient centered decision making in the choice of treatment for acute appendicitis. Survey evaluates patients experience with decision making and the types of decision support they receive.
What is the current status of trial NCT04968782?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2021-07-12. Estimated completion is 2022-02-16.
What interventions are being tested in trial NCT04968782?
The interventions under investigation include: Patients with acute appendicitis (OTHER).
Who is sponsoring clinical trial NCT04968782?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI